Press Brief

Integrated sequencing in AML/MDS reveals prognostic constellations 6:22
Integrated sequencing in AML/MDS reveals prognostic constellations
Ilaria Iacobucci • 7 Dec 2019
BCL11A as therapeutic target in SCD: gene therapy trial 7:02
BCL11A as therapeutic target in SCD: gene therapy trial
David Williams
CANDOR results reveal new regimen for RRMM: KdD 6:36
CANDOR results reveal new regimen for RRMM: KdD
Saad Usmani
Promising results for blinatumomab in younger relapsed B-ALL 4:36
Promising results for blinatumomab in younger relapsed B-ALL
Patrick Brown • 10 Dec 2019
Practice-changing potential from Cardinal: sutimlimab in CAD 6:28
Practice-changing potential from Cardinal: sutimlimab in CAD
Alexander Röth • 10 Dec 2019
BCMA-CD38 bispecific CAR-T cells in R/R MM 6:34
BCMA-CD38 bispecific CAR-T cells in R/R MM
Yu Hu • 9 Dec 2019
CARTITUDE-1 results: CAR-T against BCMA in R/R MM 7:42
CARTITUDE-1 results: CAR-T against BCMA in R/R MM
Deepu Madduri • 9 Dec 2019
Mosunetuzumab induces CR in B-NHL R/R to CAR-T 9:26
Mosunetuzumab induces CR in B-NHL R/R to CAR-T
Stephen Schuster • 8 Dec 2019
FT596: iPSC-derived CAR-NK cells with engineered persistence for B-cell malignancies 8:54
FT596: iPSC-derived CAR-NK cells with engineered persistence for B-cell malignancies
Bahram Valamehr • 7 Dec 2019
Hu5F9 plus rituximab to overcome resistance in refractory lymphoma 12:38
Hu5F9 plus rituximab to overcome resistance in refractory lymphoma
Mark Roschewski
ASCEND-ing results: acalabrutinib is well-tolerated and highly effective in R/R CLL 10:21
ASCEND-ing results: acalabrutinib is well-tolerated and highly effective in R/R CLL
Paolo Ghia
Venetoclax with bortezomib/dexamethasone: phase 3 BELLINI results in R/R myeloma 8:11
Venetoclax with bortezomib/dexamethasone: phase 3 BELLINI results in R/R myeloma
Shaji Kumar
EHA 2019 program: insights from the Chair of the Scientific Program Committee 2:01
EHA 2019 program: insights from the Chair of the Scientific Program Committee
Maria-Victoria Mateos • 14 Jun 2019
New double targeting approach for beta-thalassemia 9:28
New double targeting approach for beta-thalassemia
Antonella Nai • 14 Jun 2019
Imetelstat provides durable transfusion independence in lower risk MDS group 9:38
Imetelstat provides durable transfusion independence in lower risk MDS group
Pierre Fenaux • 14 Jun 2019
Pregnancy outcomes in CML patients 6:56
Pregnancy outcomes in CML patients
Ekaterina Chelysheva
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals